Recursion Pharmaceuticals Inc - Ordinary Shares - Class A XNAS: RXRX

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 1.144875125
Author: Trendlyne DVM scores

Momentum Trap

Download real time

6.68 0.20 (3.09%)

45.95% Fall from 52W High

17.8M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

9.2 / 100

Technically Neutral

49.1 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

9

1Yr Price target upside is 35%

7 analysts

Recursion Pharmaceuticals ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A FAQ

How is Recursion Pharmaceuticals Inc - Ordinary Shares - Class A today?

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A today is trading in the green, and is up by 3.09% at 6.68.

How has Recursion Pharmaceuticals Inc - Ordinary Shares - Class A performed historically?

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A is currently trading up 3.09% on an intraday basis. In the past week the stock rose 5.20%. stock has been up 10.78% in the past quarter and fell -36.32% in the past year. You can view this in the overview section.